Levosulpiride or sulpiride

This classification denotes a dopamine antagonist with the molecular formula C15H23N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7MNE9M8287, chemically known as o-anisamide, n-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-, (s)-(-)- but generally known as sulpiride, which bears US NIH Compound Identifier 5355. European Medicines Agency schedules Sulpiride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10758MIG. The term SULPIRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules sulpiride in its Anatomical Therapeutic Chemical (ATC) Classification. SULPIRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Levosulpiride or sulpiride bears US NLM identifiers UMLS ID C0038803 and NCI Concept Code C87713. SMILES: S(=O)(=O)(N)C1CC(C(=O)NCC2N(CCC2)CC)C(OC)CC1.